Comparison
Lion's Mane vs Semaglutide
Side-by-side of Lion's Mane and Semaglutide. Every row below is pulled from the compound schema and will update as our data grows. For deeper reads, follow through to each compound page.
Lion's Mane
Lion's mane mushroom (Hericium erinaceus) supplement profile: hericenones and erinacines stimulate NGF in vitro. Human cognition trials are small.
Semaglutide
Semaglutide for weight loss: GLP-1 agonist (Ozempic, Wegovy) drives 15-17% mean loss at 2.4 mg/week in STEP trials. Watch lean-mass loss.
Effects at a glance
Lion's Mane
- •Edible medicinal mushroom containing NGF-stimulating hericenones and erinacines
- •Mori 2009 trial (n=30) in mild cognitive impairment showed cognitive improvement at 3 g/day for 16 weeks, reversing 4 weeks after discontinuation
- •Saitsu 2019 (n=31) in older adults reported MoCA improvements at 3.2 g/day over 12 weeks
- •Multiple small mood trials suggest reduced anxiety and depression scores at 1 to 4 g/day extract
- •Mechanistic case rests on NGF stimulation and remyelination support; in vivo human NGF measurement is absent
- •Product quality varies substantially; mycelium-on-grain products can be over 50% grain by weight
Semaglutide
- •Long-acting GLP-1 receptor agonist with a ~7-day half-life that supports once-weekly subcutaneous dosing
- •STEP trials reported ~15 to 17% mean body-weight loss at 2.4 mg/week over 68 weeks in adults with obesity
- •Lowers HbA1c by ~1.0 to 1.8 percentage points in type 2 diabetes versus placebo
- •SELECT trial showed reduced major cardiovascular events in adults with prior CVD and overweight or obesity
- •Up to 25 to 40% of weight lost can be lean mass; pairing with resistance training and protein intake mitigates this
- •GI effects (nausea, vomiting, constipation) drive most discontinuations and ease with slow titration
Side-by-side
| Attribute | Lion's Mane | Semaglutide |
|---|---|---|
| Category | natural | pharmaceutical |
| Also known as | Hericium erinaceus, Yamabushitake, Bearded Tooth, Hou Tou Gu | Ozempic, Wegovy, Rybelsus |
| Half-life (hr) ↗ | 6 | 168 |
| Typical dose (mg) ↗ | 1000 | 2.4 |
| Dosing frequency | 1 to 2 times daily | weekly (SC); daily (oral Rybelsus) |
| Routes | oral | subcutaneous, oral |
| Onset (hr) | 168 | 24 |
| Peak (hr) | 1344 | 72 |
| Molecular weight | - | 4113.58 |
| Molecular formula | mixed extract | - |
| Mechanism | Hericenones and erinacines stimulate NGF mRNA expression and NGF protein release in cultured neurons; secondary anti-inflammatory and remyelination-supportive activity in preclinical models. | Long-acting GLP-1 receptor agonist; potentiates glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and acts on hypothalamic satiety centers. |
| Legal status | Dietary supplement and food worldwide; unscheduled and unrestricted | Prescription only (FDA-approved, EMA-approved) |
| WADA status | allowed | allowed |
| DEA / Rx | OTC supplement and food | Rx only (not a controlled substance); FDA-approved for type 2 diabetes (2017) and chronic weight management (2021) |
| Pregnancy | Insufficient data for routine supplementation; consumed historically as food without documented harm | Not recommended; discontinue 2 months before planned pregnancy |
| CAS | 910463-68-2 | |
| PubChem CID | 56843331 | |
| Wikidata | Q146050 | Q27089394 |
Safety profile
Lion's Mane
Common side effects
- mild GI upset
- occasional skin rash
- contact dermatitis (rare)
Contraindications
- mushroom allergy
Interactions
- anticoagulants: theoretical antiplatelet effect, no documented clinical events(minor)
Semaglutide
Common side effects
- nausea
- vomiting
- diarrhea
- constipation
- decreased appetite
- injection-site reactions
- fatigue
Contraindications
- personal or family history of medullary thyroid carcinoma
- multiple endocrine neoplasia type 2
- pregnancy
- history of pancreatitis (use caution)
Interactions
- insulin: additive hypoglycemia risk; insulin dose typically reduced(major)
- sulfonylureas (glipizide, glyburide): hypoglycemia risk, sulfonylurea dose often reduced(major)
- oral medications (general): delayed gastric emptying can alter absorption kinetics(moderate)
- warfarin: monitor INR due to altered absorption(moderate)
Which Should You Take?
Lion's Mane comes out ahead for most readers on the criteria we weight: 3 catalogued goals, OTC dietary supplement, oral dosing, with a Tier-B outcome catalogued. Semaglutide is the right call when one of the conditionals below applies.
- → If your priority is focus or working memory, pick Lion's Mane.
- → If your priority is nerve health, pick Lion's Mane.
- → If your priority is metabolic health and glucose control, pick Semaglutide.
- → If your priority is fat loss, pick Semaglutide.
Edge case: If you want to avoid prescription-only, Lion's Mane is the more accessible choice.
Default choice: Lion's Mane. Lower friction to source, and broader goal coverage. Reach for Semaglutide only if your priority sits squarely in the goals it owns above.
This verdict is generated from each compound's schema (goals, legal status, evidence outcomes, dosing route). It updates automatically as our compound data evolves; the deeper read sits on each individual compound page.
Common questions
What is the difference between Lion's Mane and Semaglutide?
Lion's Mane and Semaglutide differ in category (natural vs pharmaceutical), mechanism, and typical dosing. See the side-by-side table for full details.
Which has a longer half-life, Lion's Mane or Semaglutide?
Lion's Mane half-life is 6 hours; Semaglutide half-life is 168 hours.
Can you stack Lion's Mane with Semaglutide?
Stack compatibility depends on mechanism overlap, legal status, and individual response. Check each compound page for specific interactions and contraindications before combining.
Go deeper